Contact

Our portfolio

Inreda Diabetic

Developing a bi-hormonal artificial pancreas, Inreda Diabetic offers a closed-loop system for diabetes management. Their device automates insulin and glucagon administration, drastically reducing the burden on patients compared to classic single-hormone pumps. Inreda Diabetic’s technology aims to improve blood glucose control and quality of life for diabetes patients.

  • Institute: Amsterdam UMC
Industry: Diabetes, Medical Technology
  • Founding year: 2007
Visit website

Want to get in contact about Inreda Diabetic?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

TrianecT
Innovating stroke diagnosis with an AI-powered portable EEG for use inside the ambulance.
Flowsure
Automating urine output monitoring for hospitalized patients.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.

GuanaRep

GuanaRep
Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.
TrianecT
Innovating stroke diagnosis with an AI-powered portable EEG for use inside the ambulance.
Flowsure
Automating urine output monitoring for hospitalized patients.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.

GuanaRep

GuanaRep
Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.
Explore full AAV portfolio
Contact